PresentER-Cassette mCherry Citations (2)
Originally described in: Rejection of immunogenic tumor clones is limited by clonal fraction.Gejman RS, Chang AY, Jones HF, DiKun K, Hakimi AA, Schietinger A, Scheinberg DA Elife. 2018 Nov 30;7. pii: 41090. doi: 10.7554/eLife.41090. PubMed Journal
Articles Citing PresentER-Cassette mCherry
| Articles |
|---|
Rejection of immunogenic tumor clones is limited by clonal fraction.
Gejman RS, Chang AY, Jones HF, DiKun K, Hakimi AA, Schietinger A, Scheinberg DA.
Elife. 2018 Nov 30;7. pii: 41090. doi: 10.7554/eLife.41090.
PubMed
Associated Plasmids |
| Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform. Gejman RS, Jones HF, Klatt MG, Chang AY, Oh CY, Chandran SS, Korontsvit T, Zakahleva V, Dao T, Klebanoff CA, Scheinberg DA. Cancer Immunol Res. 2020 May;8(5):672-684. doi: 10.1158/2326-6066.CIR-19-0745. Epub 2020 Mar 17. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.